Dr Reddys Laboratories (RDY) Long-Term Investments (2009 - 2026)
Dr Reddys Laboratories (RDY) posted Long-Term Investments of $848.2 million for Q2 2026, down 6.74% on a QoQ basis from $909.5 million in Q1 2026, and up 25.85% year-over-year from $674.0 million in Q2 2025.
Powered by 
Analysis
Dr Reddys Laboratories (RDY) Long-Term Investments (2009 - 2026) Analysis & Trends
Dr Reddys Laboratories has reported Long-Term Investments for 18 years, with the latest figure at $848.2 million in Q2 2026.
- On a quarterly basis, Long-Term Investments rose 25.85% year-over-year to $848.2 million in Q2 2026; TTM through Jun 2026 was $848.2 million, a 25.85% increase from a year earlier, with the FY2026 full-year figure at $772.0 million, up 52.57% from the prior year.
- Long-Term Investments was $848.2 million for Q2 2026 at Dr Reddys Laboratories, down from $909.5 million in the prior quarter.
- The five-year high for Long-Term Investments was $909.5 million in Q1 2026, with the low at $11.7 million in Q2 2024.
- Average Long-Term Investments over 5 years is $601.4 million, with a median of $665.2 million recorded in 2025.
- The sharpest annual moves came in 2024 and 2025: Long-Term Investments sank 98.22% in 2024, then soared 5678.62% in 2025.
- Over 5 years, Long-Term Investments stood at $534.8 million in 2022, then jumped by 46.01% to $780.8 million in 2023, then slipped by 28.88% to $555.4 million in 2024, then jumped by 38.58% to $769.6 million in 2025, then climbed by 10.22% to $848.2 million in 2026.
- The last three Long-Term Investments figures came in at $848.2 million (Q2 2026), $909.5 million (Q1 2026), and $769.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 46.72 Bn | 43.07 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.64 Bn | 18.75 Bn | 1.46 Bn | - |
| 3 | Dr Reddys Laboratories | 10.36 Bn | 10.22 Bn | 396.53 Mn | 848.23 Mn |
| 4 | Amneal Pharmaceuticals | 6.44 Bn | 6.39 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.11 Bn | 1.24 Bn | 2.10 Bn | - |
| 6 | Ani Pharmaceuticals | 1.88 Bn | 1.52 Bn | 165.89 Mn | - |
| 7 | Alvotech | 1.83 Bn | 1.69 Bn | 2.56 Mn | - |
| 8 | Amphastar Pharmaceuticals | 1.04 Bn | 751.07 Mn | 93.47 Mn | 16.30 Mn |
| 9 | Fennec Pharmaceuticals | 382.22 Mn | 340.97 Mn | 17.15 Mn | - |
| 10 | NutriBand | 94.45 Mn | 91.03 Mn | 181,874.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 848.23 Mn |
| Mar 31, 2026 | 909.49 Mn |
| Dec 31, 2025 | 769.60 Mn |
| Sep 30, 2025 | 686.81 Mn |
| Jun 30, 2025 | 674.02 Mn |
| Mar 31, 2025 | 499.50 Mn |
| Dec 31, 2024 | 555.35 Mn |
| Sep 30, 2024 | 617.79 Mn |
| Jun 30, 2024 | 11.66 Mn |
| Mar 31, 2024 | 895.45 Mn |
| Dec 31, 2023 | 780.82 Mn |
| Sep 30, 2023 | 680.40 Mn |
| Jun 30, 2023 | 656.47 Mn |
| Mar 31, 2023 | 681.45 Mn |
| Dec 31, 2022 | 534.76 Mn |
| Sep 30, 2022 | 253.49 Mn |
| Jun 30, 2022 | 378.30 Mn |
| Mar 31, 2022 | 392.50 Mn |
| Dec 31, 2021 | 207.94 Mn |
| Sep 30, 2021 | 245.74 Mn |
API Access
Dr Reddys Laboratories Long-Term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-investments&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-investments", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-investments&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();